Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat

Peptides

Volumn 27, Issue 9, 2006, Pages 2258-2270

  Yamaguchi, Naoto ^a   Jesmin, Subrina ^b   Zaedi, Sohel ^b   Shimojo, Nobutake ^b   Maeda, Seiji ^b   Gando, Satoshi ^c   Koyama, Akio ^a   Miyauchi, Takashi ^b  

^a IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Endothelin; Kidney; Nitric oxide; Sepsis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DOWN REGULATION; ENDOTOXEMIA; HISTOPATHOLOGY; HYPOTENSION; HYPOTHESIS; KIDNEY ARTERY VASOCONSTRICTION; KIDNEY DISEASE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENOVASCULAR DISEASE; SEPSIS; SYSTOLIC BLOOD PRESSURE; UPREGULATION; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; ENDOTOXEMIA; KIDNEY; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS NORVEGICUS;

EID: 33746919980     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.03.025     Document Type: Article

References (66)

1. 2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 42 (2003) 600-604
2. Ahn K.Y., Mohaupt M.G., Madsen K.M., and Kone B.C. In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. Am J Physiol 267 (1994) F748-F757
3. Barron R.L. Pathophysiology of septic shock and implications for therapy. Clin Pharm 11 (1993) 829-845
4. Boffa J.J., and Arendshorst W.J. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol 16 (2005) 117-124
5. Bone R.C. The pathogenesis of sepsis. Ann Intern Med 115 (1991) 457-469
6. Brauner J.S., Rohde L.E., and Clausell N. Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock. Intens Care Med 26 (2000) 305-313
7. Ehrenreich H., Anderson R.W., Fox C.H., Rieckmann P., Hoffman G.S., Travis W.D., et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 172 (1990) 1741-1748
8. Filep J.G., Bodolay E., Sipka S., Gyimesi E., Csipo I., and Szegedi G. Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease. Circulation 92 (1995) 2969-2974
9. Filep J.G. Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats. Br J Pharmacol 129 (2000) 975-983
10. Fink M.P., and Heard S.O. Laboratory models of sepsis and septic shock. J Surg Res 49 (1990) 186-196
11. Fink M.P. Modulating the l-arginine-nitric oxide pathway in septic shock: choosing the proper point of attack. Crit Care Med 27 (1999) 2019-2022
12. Gardiner S.M., Kemp P.A., March J.E., and Bennett T. Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670. Br J Pharmacol 116 (1995) 1718-1719
13. Gardiner S.M., Kemp P.A., March J.E., Bennett T., Davenport A.P., and Edvinsson L. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol 112 (1994) 477-486
14. Guo Y., Cernacek P., Giaid A., and Hussain S.N. Production of endothelins by the ventilatory muscles in septic shock. Am J Respir Cell Mol Biol 19 (1998) 470-476
15. Hartemink K.J., Groeneveld A.B., de Groot M.C., Strack van Schijndel R.J., van Kamp G., and Thijs L.G. Alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med 29 (2001) 80-87
16. Hemsen A., Modin A., and Weitzberg E. Increased concentrations of endothelin-1 messenger RNA in tissues and endothelin-1 peptide in plasma in septic pigs: modulation by betamethasone. Crit Care Med 24 (1996) 1530-1536
17. Ikeda U., Kurosaki K., Ohya K., and Shimada K. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc Res 35 (1997) 168-174
18. Kaw S., Hecker M., and Vane J.R. The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 89 (1992) 6886-6890
19. Kilbourn R. Nitric oxide synthase inhibitors-a mechanism-based treatment of septic shock. Crit Care Med 27 (1999) 857-858
20. Kim S., and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52 (2000) 11-34
21. Kone B.C. Nitric oxide in renal health and disease. Am J Kid Dis 30 (1997) 311-333
22. Landry D.W., and Oliver J.A. The pathogenesis of vasodilatory shock. N Engl J Med 345 (2001) 588-595
23. Laubach V.E., Shesely E.G., Smithies O., and Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92 (1995) 10688-10692
24. Lee K.Y., Perretta S.G., Zar H., Mueller R.A., and Boysen P.G. Increase in rat plasma antioxidant activity after E. coli lipopolysaccharide administration. Yonsei Med J 42 (2001) 114-119
25. Lorente J.A., Landin L., Renes E., De Pablo R., Jorge P., Rodena E., et al. Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 21 (1993) 759-767
26. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81 (1995) 641-650
27. Maeda S., Miyauchi T., Iemitsu M., Tanabe T., Yokota T., Goto K., et al. Effects of exercise training on expression of endothelin-1 mRNA in the aorta of aged rats. Clin Sci 103 (2002) 118S-123S
28. Marsden P.A., and Brenner B.M. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 262 (1992) C854-C861
29. Mayeux P.R. Pathobiology of lipopolysaccharide. J Toxicol Environ Health 51 (1997) 415-435
30. Mezzano S., Ruiz-Ortega M., and Egido J. Angiotensin II and renal fibrosis. Hypertension 38 (2001) 635-638
31. Millar C.G.M., and Thiemermann C. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol 121 (1997) 1824-1830
32. Mitaka C., Hirata Y., Yokoyama K., Nagura T., Tsunoda Y., and Amaha K. Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist. Crit Care Med 27 (1999) 146-153
33. Mohaupt M.G., Elzie J.L., Ahn K.Y., Clapp W.L., Wilcox C.S., and Kone B.C. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kid Int 46 (1994) 653-665
34. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
35. Morrissey J.J., McCracken R., Kaneto H., Vehaskari M., Montani D., and Klahr S. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kid Int 45 (1994) 998-1005
36. Myers P.R., Zhong Q., Jones J.J., Tanner M.A., Adams H.R., and Parker J.L. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia. Am J Physiol 268 (1995) H955-H961
37. Nakamura T., Kasai K., Sekiguchi Y., Banba N., Takahashi K., Emoto T., et al. Elevation of plasma endothelin concentrations during endotoxin shock in dogs. Eur J Pharmacol 205 (1991) 277-282
38. Navar L.G., Harrison-Bernard L.M., Nishiyama A., and Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 39 (2002) 316-322
39. Niimi R., Nakamura A., and Yanagawa Y. Suppression of endotoxin-induced renal tumor necrosis factor-alpha and interleukin-6 mRNA by renin-angiotensin system inhibitors. Jpn J Pharmacol 88 (2002) 139-145
40. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 328 (1993) 1471-1477
41. Pernow J., Hemsen A., Hallen A., and Lundberg J.M. Release of endothelin-like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pig. Acta Physiol Scand 140 (1990) 311-322
42. Pittet J.F., Morel D.R., Hemsen A., Gunning K., Lacroix J.S., Suter P.M., et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213 (1991) 261-264
43. Preiser J.C., Zhang H., Vray B., Hrabak A., and Vincent J.L. Time course of inducible nitric oxide synthase activity following endotoxin administration in dogs. Nitric Oxide Biol Chem 5 (2001) 208-211
44. Rackow E.C., and Astiz M.E. Pathophysiology and treatment of septic shock. JAMA 266 (1991) 548-554
45. Ruetten H., Thiemermann C., and Vane J.R. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Br J Pharmacol 118 (1996) 198-204
46. Schrier R.W., and Wang W. Acute renal failure and sepsis. N Engl J Med 351 (2004) 159-169
47. Schwartz D., and Blantz R.C. Nitric oxide, sepsis, and the kidney. Semin Nephrol 19 (1999) 272-276
48. Schwobel J., Fischer T., Lanz B., and Mohaupt M. Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells. Am J Physiol Renal Physiol 279 (2000) F1092-F1100
49. Siragy H.M. AT1 and AT2 receptor in the kidney: role in health and disease. Semin Nephrol 24 (2004) 93-100
50. Sugiura M., Inagami T., and Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 161 (1989) 1220-1227
51. Suzuki Y., Ruiz-Ortega M., Lorenzo O., Ruperez M., Esteban V., and Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 35 (2003) 881-900
52. Szabo C., Cuzzocrea S., Zingarelli B., O'Connor M., and Salzman A.L. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100 (1997) 723-735
53. Takakuwa T., Endo S., Nakae H., Kikichi M., Suzuki T., Inada K., et al. Plasma levels of TNF-alpha, endothelin-1 and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol 84 (1994) 261-269
54. Taylor B.S., and Geller D.A. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13 (2000) 413-424
55. Thiemermann C., Szabo C., Mitchell J.A., and Vane J.R. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 90 (1993) 267-271
56. Titheradge M.A. Nitric oxide in septic shock. Biochim Biophys Acta 1411 (1999) 437-455
57. Unger T. Blood pressure lowering and renin-angiotensin system blockade. J Hypertens Suppl 21 (2003) S3-S7
58. Vemulapalli S., Chiu P.J., Rivelli M., Foster C.J., and Sybertz E.J. Modulation of circulating endothelin levels in hypertension and endotoxemia in rats. J Cardiovasc Pharmacol 18 (1991) 895
59. Voerman H.J., Stehouwer C.D., van Kamp G.J., Strack van Schijndel R.J., Groeneveld A.B., and Thijs L.G. Plasma endothelin levels are increased during septic shock. Crit Care Med 20 (1992) 1097-1101
60. Wagner O.F., Christ G., Wojta J., Vierhapper H., Parzer S., Nowotny P.J., et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267 (1992) 16066-16068
61. Wang W., Falk S.A., Jittikanont S., Gengaro P.E., Edelstein C.L., and Schrier R.W. Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. Am J Physiol 283 (2002) F583-F587
62. Wardle N. Acute renal failure in the 1980s: the importance of septic shock and of endotoxaemia. Nephron 30 (1982) 193-200
63. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995) 408-411
64. Weitzberg E., Lundberg J.M., and Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33 (1991) 222-227
65. Yamamoto S., Burman H.P., O'Donnell C.P., Cahill P.A., and Robotham J.L. Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. Am J Physiol 272 (1997) H1239-H1249
66. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415